Vaishali Pharma P/E Ratio
Current P/E Ratio
22.53
Moderate Valuation
High - Growth expectations or overvalued
Vaishali Pharma (VAISHALI) P/E ratio is 22.53 (Moderate), EPS (TTM) ₹0.31, current price ₹8.80 on NSE — High - Growth expectations or overvalued. See VAISHALI price to book ratio to compare market price against book value per share.
Current Valuation Metrics
P/E Ratio
22.53
Current Price
₹8.80
EPS (TTM)
₹0.31
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.42
Sector Median
31.4
Sector Rank
#11 of 194
Sector Percentile
5.7%
Earnings Breakdown (TTM)
TTM EPS
₹0.32
Mar 2026
₹0.03
Sept 2025
₹0.09
VAISHALI P/E Ratio — Valuation Signal & Historical Context
Vaishali Pharma P/E 22.53 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see VAISHALI screener.
- Trading at discount to sector average PE of 55.42
VAISHALI vs Healthcare Peers — P/E Ratio Comparison
Vaishali Pharma P/E 22.53 vs Healthcare average 55.42, median 31.4 — range 2.86–987.08.
Sector Average
55.42
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
987.08
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |